Pulitzer-winning combat journalist warns of media's "hype songs and war toy cheers" after Trump drops MOAB
Donald Trump’s decision to drop a massive bomb in Afghanistan prompted a Pulitzer Prize-winning combat journalist to warn about the media’s habit of cheering for spectacular weapons of war. C.J. Chivers, Moscow bureau chief for the New York Times and two-time Pulitzer winner, reacted to the news, writing, “Last week, Tomahawks. This week the MOAB. […]
C.J. Chivers, Moscow bureau chief for the New York Times and two-time Pulitzer winner, reacted to the news, writing, “Last week, Tomahawks. This week the MOAB. Stand by for certain news voices to to pound out hype songs and war-toy cheers.”
Last week, Tomahawks. This week the MOAB. Stand by for certain news voices to to pound out hype songs and war-toy cheers. pic.twitter.com/7jusQY8LAm
— C.J. Chivers (@cjchivers) April 13, 2017
The Pentagon announced that the GBU-43 bomb, known as the “Mother of All Bombs” (MOAB), had been deployed on an “ISIS-K tunnel complex in Achin district” in Afghanistan.
The MOAB is a 21,600-pound GPS-guided bomb that is the most powerful non-nuclear weapon in the American arsenal. It has never been used in combat before.
The national mainstream media has a historical love affair with military weapons and the dazzling footage that often accompanies their deployment. Instead of questioning why these weapons have been used and the human toll accompanying these decisions, the press – particularly TV news – tends to wax rhapsodic about such displays of “shock and awe.”
MSNBC’s Brian Williams was widely condemned when he referred to the recent airstrikes in Syria as “beautiful,” and more of the same could accompany the MOAB deployment.
Chivers’ warning could be prophetic, and Americans could be forced to brace for another round of a deadly game.
Recommended
Grift alert: Trump’s cabinet picks push dubious products
Dr. Mehmet Oz, Trump’s pick to manage Medicare and Medicaid, is under scrutiny for selling herbal supplements.
By Jesse Valentine - December 05, 2024Trump breaks presidential norms and traditions with FBI pick
The current FBI director’s term ends in 2027.
By Jesse Valentine - December 04, 2024Republican Larry Hogan takes in thousands from big pharma in final months of campaign
Hogan refused to sign a state law that banned price gouging by drugmakers.
By Jesse Valentine - October 30, 2024